Abortion providers sue FDA in a Virginia federal court over mifepristone restrictions
Abortion providers in Virginia, Montana and Kansas sued the FDA on Monday in federal court over mifepristone prescribing restrictions, called Risk Evaluation and Mitigation Strategy, or REMS.
The longstanding REMS for mifepristone are under fire in the District Court for the Western District of Virginia, where providers are trying to force the FDA to drop the restrictions. The lawsuit was filed on behalf of the providers, including Whole Woman’s Health Alliance, by the Center for Reproductive Rights, a New York-based legal and advocacy group.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.